Navigation Links
Barrow researcher reports that slow breathing reduces pain
Date:1/20/2010

Research performed by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has shown that controlled breathing at a slowed rate can significantly reduce feelings of pain.

Chronic pain sufferers, specifically fibromyalgia (FM) patients, also reported less pain while breathing slowly, unless they were overwhelmed by negative feelings, sadness or depression.

The research was led by Arthur (Bud) Craig, PhD, at Barrow, and was done in collaboration with investigators in the Department of Psychology at Arizona State University. It was published recently in PAIN, the refereed journal of the International Association for the Study of Pain (IASP). The findings offer an explanation for prior reports that mindful Zen meditation has beneficial effects on pain and that yogic breathing exercises can reduce feelings of depression. These results also underline the role that a person's positive or negative attitude can have on their feelings of pain.

The study involved two groups of women aged 45 to 65. One group was composed of women previously diagnosed with fibromyalgia, and the other group was "healthy controls."

During the trial, participants were subjected to moderately painful heat pulses on their palms. The heat pulses were administered while they were breathing at normal rates and when participants reduced their breathing rates by 50 percent. After each heat pulse, participants were asked to report their feelings three ways: how strong the pain was (pain intensity), how uncomfortable it was (pain unpleasantness) and how their mood varied (affect).

The researchers analyzed the participants' ratings of pain intensity and unpleasantness and found an overall reduction in reported pain when the healthy control participants were paced to breathe slowly. However, fibromyalgia patients benefited from slow breathing only if they reported positive affect.

Other studies have shown that depression is a hallmark of fibromyalgia and that the connection between pain and emotion is particularly evident in people diagnosed with the fibromyalgia syndrome.

Results of the Barrow study showed that FM patients as a whole did not show a lessening of pain when breathing slowly, but those FM patients with strong positive affect as a trait (meaning it is an aspect of their personality, not simply the situation) did show some improvement. "This fits with the idea that FM patients in general have low positive affect, or energy reserves. Those who do have some positive energy left in their "mental battery" can use it to reduce pain by breathing slowly, just like healthy normals," says Dr. Craig.


'/>"/>

Contact: Lynne Reaves
Lynne.Reaves@chw.edu
602-406-4734
St. Joseph's Hospital and Medical Center
Source:Eurekalert

Related medicine news :

1. Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
2. Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Shareholder Class Action Filed Against Health Management Associates, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
4. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Shareholder Class Action Filed Against NeuroMetrix Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
6. Shareholder Class Action Filed Against Humana Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. Shareholder Class Action Filed Against Candela Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Shareholder Class Action Filed Against WellPoint, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
9. Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan
10. Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated ... regulations. This is the first time that Coolsculpting is being used for for ... six months to ensure they meet the prescribed body-fat standard, measured by the circumference-based ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... trusted name in the pharmaceutical, medical and food industries. Aside from its GMP ... certification (SIC), providing proof of successfully certified products, services and staff. , Validation ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... May 26, 2016 A key ... is the emergence of new treatments. Cardax, a development ... osteoarthritis treatment. The therapy is expected to fulfil large ... UK is conducting studies to develop new treatments for ... the genes involved in osteoarthritis are being investigated, and ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
Breaking Medicine Technology: